Navigation Links
Rheumatoid arthritis is a risk factor for cardiovascular disease
Date:6/13/2008

Paris, France, Friday 13 June 2008: The risk of cardiovascular disease (CVD) for people with rheumatoid arthritis (RA) has been found to be comparable to the risk of CVD in people with type 2 diabetes, according to the conclusions of two studies presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

At least one CV-event was reported in 8.6% of the RA population studied, a figure that was double that reported in the general population (4.3%), corresponding with an incidence of 3.14 per 100 patient/years (95% confidence interval (CI): 1.98-4.30) for RA patients, and 1.51 per 100 person/years (95%-CI: 1.18-1.84) for the general population.

In a second study, the age- and gender- adjusted prevalence odds ratios for CVD were found to be 2.3 (95%-CI: 1.3-4.0) for those with type 2 diabetes and 2.0 (95%-CI: 1.1-3.4) for those with RA, indicating a similar CVD risk for the two diseases.

Dr Mike Peters of the VU University Medical Center and Jan van Breemen Institute, Amsterdam, the Netherlands, an investigator in both studies (lead investigator: Dr Michael T Nurmohamed), said, "These two studies suggest that RA should be considered an important cardiovascular disease risk factor. Healthcare professionals treating those with the disease should therefore be aware of this elevated risk and advise their patients to follow a healthy diet and lifestyle and be alert to the early signs and symptoms of CVD in addition to managing their RA."

The studies both examined 353 randomly selected outpatients with RA (from the CARR study) and participants of a population-based cohort study on diabetes and CVD (the Hoorn study). The first study compared 3-year incident CVD in both the CARR and Hoorn studies, using Cox proportional hazards models. In the second, patients with normal fasting glucose levels from the CARR study (n=294) were compared to individuals from the Hoorn study with a normal glucose metabolism (n=258) and individuals with type 2 diabetes (n=194). Both made adjustments for other CV risk factors, i.e. blood pressure, anti-hypertensive agent use, total cholesterol, statin use, waist to hip ratio and smoking.


'/>"/>

Contact: Rory Berrie / Camilla Dormer
eularpressoffice@uk.cohnwolfe.com
44-077-892-70392
European League Against Rheumatism
Source:Eurekalert

Related medicine news :

1. Novel DNA microarray chip predicts functional impairment and remission in rheumatoid arthritis
2. Early life infections increase the risk of rheumatoid arthritis and juvenile idiopathic arthritis
3. Rheumatoid arthritis factors equal to cardiovascular factors in risk of severe cardiovascular events
4. New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
5. HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity
6. Hand bone mineral density is an effective predictor of mortality in rheumatoid arthritis
7. Biogen Idecs baminercept alfa shows promise in patients with rheumatoid arthritis
8. Golimumab Eases Rheumatoid Arthritis Symptoms
9. Researchers uncover higher prevalence of periodontal disease in rheumatoid arthritis patients
10. Drinking Cuts Rheumatoid Arthritis Risk
11. Regular tipple may curb risk of rheumatoid arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... The Rett Syndrome Research ... neurological disorder that afflicts 350,000 individuals worldwide. Rett Syndrome is caused by ... exclusively strikes females. Following a normal infancy, Rett Syndrome takes effect in ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... Bragdon to its Department of Orthopedic Surgery, Division of Hand, Upper Extremity and ... orthopedic surgery. She is board-certified in both Orthopedics and Hand Surgery. ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... lab with extensive therapeutic experience and operational excellence in oncology clinical trials, proudly ... trial for the treatment of non-small cell lung cancer and small cell lung ...
(Date:3/22/2017)... NY (PRWEB) , ... March 22, 2017 , ... The ... communities in the greater Nassau County region, is embarking on a combined charity effort ... cancer. , For the last 25 years, the Great Neck Breast Cancer Coalition ...
(Date:3/22/2017)... ... March 22, 2017 , ... Schneider Insurance and Financial, a southern ... throughout the Yellowstone Valley region, is launching a charity event aimed at raising local ... in all of Montana State, and is home to a broad variety of animals ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , March 22, 2017 Piramal ... Organization (CDMO), held a special event to introduce the ... Lexington, Kentucky . The inaugural event ... Group Chairman Ajay Piramal, and Piramal Pharma Solutions ... ...
(Date:3/22/2017)... , March 22, 2017 FinancialBuzz.com News ... According to ... was worth an estimated $6.6 billion in 2016, and is projected ... or reaching more than $24 billion by 2025. The medical cannabis ... growing from $4.7 billion in 2016, to an estimated $13.3 billion ...
(Date:3/22/2017)... ROCKLAND, Mass. , March 22, 2017 EMD ... Germany , in the U.S. and Canada ... be presented during the poster presentation session at the 65 ... Indian Wells, California on March 24 ... on analyses of a real-world database collected from July 2009 ...
Breaking Medicine Technology: